Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.635    -0.015 (-0.57%)
Bid:
2.635
Ask:
2.64
Spread: 0.005 (0.19%)
Market Cap: $8.69b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB 1H2025 Condensed Separate Financials

22 Jul 2025 07:00

RNS Number : 9511R
Commercial Intnl Bank (Egypt) SAE
22 July 2025
Β 
Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/9511R_1-2025-7-21.pdfΒ 

Condensed Separate Interim Statement of Financial Position as at June 30, 2025

Notes

Jun. 30, 2025

Β 

Dec. 31, 2024

Β 

Β 

Β 

Assets

Β 

Cash and balances at the central bank

9

100,535,373

Β 

136,165,920

Due from banks

10

231,774,988

Β 

270,089,441

Loans and advances to banks, net

12

28,273,497

Β 

9,555,410

Loans and advances to customers, net

13

419,494,572

Β 

340,955,698

Derivative financial instruments

1,165,796

Β 

819,711

Financial investments

Β 

Β 

Β 

- Financial Assets at Fair Value through OCI

14

262,186,573

Β 

233,029,903

- Financial Assets at Amortized cost

14

210,324,232

Β 

167,276,956

Investments in subsidiaries and associates

15

853,165

Β 

871,525

Non-current assets held for sale

29

159,828

Β 

159,828

Other assets

16

52,719,250

Β 

44,175,232

Deferred tax assets

2,558,253

Β 

2,337,304

Property and equipment

17

4,577,331

3,881,620

Total assets

Β 

1,314,622,858

Β 

1,209,318,548

Β 

Liabilities and equity

Β 

Β 

Β 

Liabilities

Β 

Β 

Β 

Due to banks

18

2,975,504

Β 

2,317,715

Due to customers

19

1,040,233,344

Β 

967,895,387

Derivative financial instruments

510,278

Β 

100,571

Current income tax liabilities

11,373,107

Β 

18,327,968

Other liabilities

20

27,329,336

Β 

21,347,499

Issued debt instruments

21

4,948,964

Β 

5,067,781

Other loans

31,250,581

Β 

23,962,389

Other provisions

22

19,927,608

18,613,060

Total liabilities

Β 

1,138,548,722

1,057,632,370

Β 

Equity

Β 

Β 

Β 

Issued and paid capital

30,708,510

Β 

30,431,580

Reserves

90,421,708

Β 

63,125,912

Reserve for employee stock ownership plan (ESOP)

1,734,177

Β 

1,868,235

Retained earnings*

Β 

53,209,741

56,260,451

Total equity and net profit for the period / year

Β 

176,074,136

151,686,178

Β 

Total liabilities and equity

Β 

1,314,622,858

1,209,318,548

Β 

The accompanying notes are an integral part of these financial statements.

Β 

(Review report attached)

Β 

*

Including net profit for the period

Β 

Islam Zekry

Hisham Ezz Al-Arab

Β 

Group CFO & Executive Board Member

CEO & Executive Board Member

Β 

Condensed Separate Interim Income Statement for the period ended June 30, 2025

Β 

Β 

Β 

Last 6 Months

Β 

Last 6 Months

Β 

Β 

Notes

Β 

Jun. 30, 2025

Β 

Jun. 30, 2024

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Interest and similar income

Β 

104,727,073

Β 

81,420,481

Β 

Interest and similar expense

Β 

(53,575,810)

(39,980,202)

Β 

Net interest income

Β 

Β 

51,151,263

41,440,279

Β 

Β 

Β 

Β 

Β 

Β 

Fee and commission income

Β 

7,416,971

Β 

5,905,503

Β 

Fee and commission expense

Β 

(3,292,751)

(2,505,646)

Β 

Net fee and commission income

Β 

Β 

4,124,220

3,399,857

Β 

Β 

Β 

Β 

Β 

Β 

Dividend income

Β 

99,052

Β 

76,025

Β 

Net trading income

6

Β 

1,241,158

Β 

17,385,406

Β 

Profits (Losses) on financial investmentsΒ 

14.1

Β 

526,717

Β 

297,208

Β 

Administrative expenses

Β 

(7,544,381)

Β 

(5,568,213)

Β 

Other operating income (expenses)

7

Β 

(3,546,143)

Β 

(16,410,949)

Β 

Impairment release (charges) for credit losses

Β 

345,831

(2,059,775)

Β 

Profit before income tax

Β 

46,397,717

38,559,838

Β 

Β 

Β 

Β 

Β 

Β 

Income tax expense

26

Β 

(13,477,682)

Β 

(11,255,055)

Β 

Deferred tax assets (Liabilities)

26

Β 

489,475

378,395

Β 

Net profit for the period

Β 

Β 

33,409,510

Β 

27,683,178

Β 

Β 

Β 

Β 

Β 

Earnings per share

8

Β 

Β 

Β 

Basic

9.69

Β 

8.11

Β 

Diluted

9.61

Β 

8.04

Β 

Β 

Β 

Β 

Β 

Β 

Β 

0

Β 

Β 

Β 

Β 

Islam Zekry

Hisham Ezz Al-Arab

Β 

Group CFO & Executive Board Member

CEO & Executive Board Member

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Statement of Comprehensive Income for the period ended June 30, 2025

Β 

Β 

Last 6 Months

Β 

Last 6 Months

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net profit for the period

Β 

Β 

33,409,510

27,683,178

Β 

Β 

Β 

Β 

Transferred to RE from financial assets at fair value through OCI

Β 

3,586

Β 

-

Net change on financial assets at fair value through comprehensive income after tax

Β 

4,622,564

Β 

4,073,707

Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income

Β 

Β 

140,134

751,734

Total comprehensive income for the period

Β 

Β 

38,175,794

Β 

32,508,619

Condensed Separate Interim Cash Flows for the period ended June 30, 2025

Β 

Β 

Β 

Notes

Jun. 30, 2025

Β 

Jun. 30, 2024

Β 

Β 

Β 

Β 

Β 

Cash flow from operating activities

Β 

Β 

Β 

Profit before income tax

Β 

46,397,717

Β 

38,559,838

Β 

Adjustments to reconcile profits to net cash provided by operating activities

Β 

Β 

Β 

Β 

Fixed assets depreciation

17

766,315

521,764

Β 

Impairment release/charge for credit losses (Loans and advances to customers and banks)

(866,683)

2,387,134

Β 

Net charged/released for other provisions

22

1,024,484

192,741

Β 

Impairment release/charge for credit losses (due from banks)

146,354

(35)

Β 

Impairment release/charge for credit losses (financial investments)

374,498

(327,324)

Β 

Impairment release/charge for other assets

-

(7,173)

Β 

Exchange revaluation differences for financial assets at fair value through OCI and AC

1,489,447

(18,461,627)

Β 

Revaluation differences impairment charge for Financial Assets at Fair value through OCI

(95,111)

1,182,360

Β 

Revaluation differences impairment charge for Financial Assets at Amortized cost

1,638

100,975

Β 

Revaluation differences impairment charge for due from banks

(2,820)

105

Β 

Net utilized/recovered for other provisions

22

(1,053)

(8,970)

Β 

Exchange revaluation differences of other provisions

22

291,117

3,707,089

Β 

Profits/losses from selling property and equipment

(6,006)

(2,184)

Β 

Profits/losses from selling financial investments at fair value through OCI

14.1

(345,157)

(297,208)

Β 

Profits/losses from selling investments in associates

14.1

(181,560)

-

Β 

Share based payments

Β 

653,254

Β 

533,219

Β 

Operating profits before changes in operating assets and liabilities

Β 

49,646,434

Β 

28,080,704

Β 

Β 

Β 

Β 

Β 

Net decrease / increase in assets and liabilities

Β 

Β 

Β 

Β 

Due from banks

75,949,504

36,256,280

Β 

Financial assets at fair value through P&L

-

(172,728)

Β 

Derivative financial instruments

24,358

164,384

Β 

Loans and advances to banks and customers

(96,438,781)

(53,204,190)

Β 

Other assets

(5,527,589)

(18,799,962)

Β 

Due to banks

18

657,789

(8,429,958)

Β 

Due to customers

19

72,337,957

182,431,141

Β 

Current income tax obligations paid

(2,104,575)

(926,384)

Β 

Other liabilities

Β 

(12,900,414)

(5,875,532)

Β 

Net cash generated from (used in) operating activities

Β 

81,644,683

Β 

159,523,755

Β 

Β 

Β 

Β 

Β 

Cash flow from investing activities

Β 

Β 

Β 

Β 

Proceeds from sale of investments in associates

339,920

7,173

Β 

Payments for investment in subsidiaries

(140,000)

(200,000)

Β 

Payments for purchases of property, equipment and branches construction

(4,429,952)

(1,262,707)

Β 

Proceeds from selling property and equipment

6,006

2,184

Β 

Proceeds from redemption of financial assets at amortized cost

4,876,544

1,240,196

Β 

Payments for purchases of financial assets at amortized cost

(48,035,713)

(69,609,595)

Β 

Payments for purchases of financial assets at fair value through OCI

(91,524,026)

(58,448,832)

Β 

Proceeds from selling financial assets at fair value through OCI

65,110,896

47,255,555

Β 

Net cash generated from (used in) investing activities

Β 

(73,796,325)

(81,016,026)

Β 

Β 

Β 

Condensed Separate Interim Cash Flows for the period ended June 30, 2025 (Cont.)

Β 

Β 

Β 

Jun. 30, 2025

Β 

Jun. 30, 2024

Β 

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Β 

Other loans

7,288,192

7,074,520

Β 

Dividends

(14,160,151)

(5,078,792)

Β 

Issued debt instruments

(118,817)

1,709,668

Β 

Capital increase

276,930

236,570

Β 

Net cash generated from (used in) financing activities

(6,713,846)

3,941,966

Β 

Β 

Β 

Β 

Β 

Net (decrease) increase in cash and cash equivalent during the period

1,134,512

82,449,695

Β 

Beginning balance of cash and cash equivalent

227,028,744

233,912,193

Β 

Cash and cash equivalent at the end of the period

Β 

228,163,256

Β 

316,361,888

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalent comprise:

Β 

Β 

Β 

Β 

Cash and balances at the central bank

9

100,535,373

Β 

43,371,479

Β 

Due from banks

231,918,739

Β 

305,020,997

Β 

Treasury bills and other governmental notes

11

123,491,120

118,676,181

Β 

Obligatory reserve balance with CBE

(76,281,994)

Β 

(25,285,404)

Β 

Due from banks with maturity more than three months

(28,050,433)

(7,684,847)

Β 

Treasury bills and other governmental notes with maturity more than three months

Β 

(123,449,549)

(117,736,518)

Β 

Total cash and cash equivalent

Β 

228,163,256

Β 

316,361,888

Β 

Condensed Separate Interim statement of changes in shareholders' equity

Β 

Β 

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Β 

Jun. 30, 2024

Β 

Β 

Beginning Balance at 1 January 2024

30,195,010

4,770,354

39,840,707

1,549,445

21,155

(16,808,265)

15,230

29,230,360

1,486,010

90,300,006

Β 

Capital increase

236,570

-

-

-

-

-

-

-

-

236,570

Β 

Transferred to reserves

-

1,438,320

22,582,085

-

1,663

-

-

(23,398,943)

(623,125)

-

Β 

Dividend paid

-

-

-

-

-

-

-

(5,366,429)

-

(5,366,429)

Β 

Net profit for the period

-

-

-

-

-

-

-

27,683,178

-

27,683,178

Β 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

-

-

-

-

Β 

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

4,073,707

-

-

-

4,073,707

Β 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,694

(2,694)

-

-

Β 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

751,734

-

-

-

751,734

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

533,219

533,219

Β 

Β Balance at 30 June 2024

30,431,580

6,208,674

62,422,792

1,549,445

22,818

(11,982,824)

17,924

28,145,472

1,396,104

118,211,985

Β 

Β 

Β 

Β 

Β 

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Β 

Jun. 30, 2025

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Beginning Balance at 1 January 2025

30,431,580

6,208,674

62,422,792

1,549,445

22,818

(7,095,741)

17,924

56,260,451

1,868,235

151,686,178

Β 

Capital increase

276,930

-

-

-

-

-

-

-

-

276,930

Β 

Transferred to reserves

-

2,771,284

19,758,610

-

2,246

-

-

(21,744,828)

(787,312)

-

Β 

Dividends paid

-

-

-

-

-

-

-

(14,714,434)

-

(14,714,434)

Β 

Net profit for the period

-

-

-

-

-

-

-

33,409,510

-

33,409,510

Β 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

3,586

-

(3,586)

-

-

Β 

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

4,622,564

-

-

-

4,622,564

Β 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

(2,628)

2,628

-

-

Β 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

140,134

-

-

-

140,134

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

653,254

653,254

Β 

Β Balance at 30 June 2025

30,708,510

8,979,958

82,181,402

1,549,445

25,064

(2,329,457)

15,296

53,209,741

1,734,177

176,074,136

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR EANXFAEPSEFA
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.